v3.26.1
Stock-Based Compensation (Tables)
 12 Months Ended
Apr. 25, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Stock-Based Compensation Expense
The table below summarizes the total stock-based compensation expense we recognized for all outstanding grants. Stock-based compensation expense is recorded in SG&A expense in the consolidated statement of income:

Fiscal Year Ended
(52 weeks)(52 weeks)(52 weeks)
(Amounts in thousands)4/25/20264/26/20254/27/2024
Equity-based awards expense
Restricted stock$8,389 $8,897 $6,959 
Performance-based shares5,836 6,276 5,109 
Stock options 286 924 1,257 
Restricted stock units issued to Directors1,177 1,303 1,101 
Total equity-based awards expense15,688 17,400 14,426 
Liability-based awards expense (1)
(54)91 152 
Total stock-based compensation expense$15,634 $17,491 $14,578 
(1)Includes deferred stock units issued to Directors, restricted stock units, and performance-based units. Compensation expense for these awards is based on the market price of our common stock on the grant date and is remeasured each reporting period based on the market value of our common shares on the last day of the reported period.
Schedule of Information about Non-Vested Share Awards
The following table summarizes information about non-vested awards as of and for the year ended April 25, 2026:

 
Shares or Units
(In Thousands)
Weighted Average Grant Date Fair Value
Non-vested awards at April 26, 2025607 $32.25 
Granted265 38.23 
Vested(212)30.66 
Canceled(60)34.63 
Non-vested awards at April 25, 2026600 34.54 
Schedule of Information about Performance-Based Shares Outstanding
The following table summarizes the performance-based shares outstanding at the maximum award amounts based upon the respective performance share agreements:
 
Shares
(In Thousands)
Weighted Average Grant Date Fair Value
Outstanding shares at April 26, 2025878 $27.77 
Granted365 35.62 
Vested(269)22.43 
Unearned or canceled(234)29.98 
Outstanding shares at April 25, 2026740 32.89 
Schedule of Share-Based Payment Arrangement, Performance Shares, Vested
The fair value of each performance-based share that we granted during fiscal 2026, 2025, and 2024 was as follows:

Grant Year
Vesting based on:
Fiscal 2026
Fiscal 2025
Fiscal 2024
Performance goals (1)
$35.62 $35.59 $25.48 
Market conditions (2)
$52.91 $54.67 $34.15 
(1)Represents the market value of our common shares on the date we granted the awards less the dividends we expect to pay before the shares vest
(2)Based on Monte Carlo valuation model
Schedule of Equity-Based Compensation Expenses Related to Performance-Based Shares
Equity-based compensation expenses related to performance-based shares recognized in our consolidated statement of income are as follows:
Fiscal Year Ended
(52 weeks)(52 weeks)(52 weeks)
(Amounts in thousands)4/25/20264/26/20254/27/2024
Fiscal 2022 grant$— $— $1,379 
Fiscal 2023 grant— 2,194 1,867 
Fiscal 2024 grant1,551 2,018 1,863 
Fiscal 2025 grant2,071 2,064 — 
Fiscal 2026 grant2,214 — — 
Total expense$5,836 $6,276 $5,109 
Schedule of Plan Activity for Stock Options
Plan activity for stock options under the above plans was as follows:
Number of Shares
(In Thousands)
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term
 (Years)
Aggregate Intrinsic Value
(In Thousands)
Outstanding at April 26, 2025633 $29.91 5.9$5,728 
Granted— — N/AN/A
Canceled(20)36.59 N/AN/A
Exercised(58)29.34 N/A523 
Outstanding at April 25, 2026555 29.73 5.03,545 
Exercisable at April 25, 2026500 $30.30 4.9$2,944